Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#71 / 100 Total
INTG - Intergroup Corp - Stock Price Chart
TickerINTG [NASD]
CompanyIntergroup Corp
CountryUSA
IndustryLodging
Market Cap28.18MEPS (ttm)-3.48
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.46EPS next 5Y-
P/B-EPS Q/Q81.41%
Dividend-Sales Q/Q13.04%
Insider Own71.58%Inst Own18.93%
Insider Trans0.81%Inst Trans-0.93%
Short Float0.93%Earnings-
Analyst Recom-Target Price-
Avg Volume4.61K52W Range10.18 - 22.30
InterGroup Corp. engages in the purchasing, development, operation, rehabilitation, and disposal of real property of various types and descriptions. It operates through the following business segments: Hotel Operations, Real Estate Operations, Investment Transactions, and Other. The Hotel Operations segment handles the business activities of hotels. The Real Estate Operations segment refers to the multi-family residential properties. The Investment Transactions segment represents the investment of the company's cash in marketable securities and other investments. The company was founded in 1985 and is headquartered in Los Angeles, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WINFIELD JOHN VPRESIDENT & CEOJun 26 '25Buy14.503,10044,9501,456,279Jul 01 05:25 PM
WINFIELD JOHN VPRESIDENT & CEOJun 27 '25Buy13.686008,2081,456,879Jul 01 05:25 PM
GONZALEZ DAVID CCOOJun 24 '25Buy12.636,06076,56332,829Jun 26 05:24 PM
GONZALEZ DAVID CCOOJun 25 '25Buy13.362,70036,08135,529Jun 26 05:24 PM
LOVE JOHN CDirectorDec 20 '24Sale14.2510,485149,4110Dec 27 06:00 AM
GME - Gamestop Corporation - Stock Price Chart
TickerGME [NYSE]
CompanyGamestop Corporation
CountryUSA
IndustrySpecialty Retail
Market Cap10.47BEPS (ttm)0.46
P/E50.74EPS this Y127.27%
Forward P/E65.00EPS next Y-52.00%
PEG-EPS past 5Y-
P/S2.85EPS next 5Y-4.22%
P/B2.10EPS Q/Q185.23%
Dividend-Sales Q/Q-16.94%
Insider Own8.64%Inst Own34.01%
Insider Trans1.34%Inst Trans5.02%
Short Float18.89%EarningsJun 10/a
Analyst Recom4.50Target Price13.50
Avg Volume14.43M52W Range18.73 - 35.81
GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm's stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Moore Daniel WilliamPFO and PAOJul 02 '25Sale23.9572117,26848,899Jul 03 04:34 PM
Robinson Mark HaymondGeneral Counsel and SecretaryJul 02 '25Sale23.951,26930,393127,836Jul 03 04:32 PM
Grube JamesDirectorJun 30 '25Buy23.715,575132,18329,439Jul 01 05:20 PM
Attal AlainDirectorApr 10 '25Buy25.7510,000257,500572,464Apr 10 04:18 PM
Cheng LawrenceDirectorApr 03 '25Buy21.545,000107,70083,000Apr 07 06:48 PM
HLT - Hilton Worldwide Holdings Inc - Stock Price Chart
TickerHLT [NYSE, S&P 500]
CompanyHilton Worldwide Holdings Inc
CountryUSA
IndustryLodging
Market Cap65.49BEPS (ttm)6.34
P/E43.46EPS this Y11.83%
Forward P/E30.47EPS next Y13.58%
PEG3.15EPS past 5Y15.11%
P/S5.80EPS next 5Y13.79%
P/B-EPS Q/Q18.80%
Dividend0.22%Sales Q/Q4.74%
Insider Own2.07%Inst Own98.16%
Insider Trans-0.88%Inst Trans-0.08%
Short Float3.83%EarningsJul 23/b
Analyst Recom2.37Target Price261.64
Avg Volume2.00M52W Range196.04 - 279.29
Hilton Worldwide Holdings, Inc. engages in the provision of hospitality businesses. It operates through the Management and Franchise, and Ownership segments. The Management and Franchise segment operates hotels of third-party owners. The Ownership segment includes owned, leased, and joint venture hotels. The company was founded by Conrad N. Hilton in 1925 and is headquartered in McLean, VA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Silcock Christopher WSee RemarksFeb 07 '25Option Exercise57.994,986289,13873,367Feb 10 05:22 PM
Silcock Christopher WSee RemarksFeb 07 '25Sale269.542,914785,44070,453Feb 10 05:22 PM
NASSETTA CHRISTOPHER JSee RemarksFeb 07 '25Option Exercise57.9971,1254,124,539118,036Feb 07 04:53 PM
NASSETTA CHRISTOPHER JSee RemarksFeb 07 '25Sale268.8340,65310,928,74677,383Feb 07 04:53 PM
Silcock Christopher WOfficerFeb 07 '25Proposed Sale269.542,914785,440Feb 07 01:49 PM
CCIF - Carlyle Credit Income Fund - Stock Price Chart
TickerCCIF [NYSE]
CompanyCarlyle Credit Income Fund
CountryUSA
IndustryClosed-End Fund - Debt
Market Cap120.74MEPS (ttm)0.30
P/E21.30EPS this Y-18.49%
Forward P/E6.20EPS next Y6.19%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend19.72%Sales Q/Q-
Insider Own0.57%Inst Own50.41%
Insider Trans59.79%Inst Trans-
Short Float0.43%EarningsMay 20/a
Analyst Recom-Target Price7.56
Avg Volume177.44K52W Range5.91 - 8.80
Carlyle Credit Income Fund is a close ended fixed income mutual fund launched and managed by Vertical Capital Asset Management, LLC. The fund is co - managed by Behringer Advisors, LLC. The Fund invests mainly in fixed-income securities. The fund invests in stocks of companies operating across diversified sectors. It seeks to benchmark the performance of its portfolio against the Barclays Capital U.S. Mortgage Backed Securities Index. Carlyle Credit Income Fund was formed on December 30, 2011 and is domiciled in the United States.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Basmadjian Lauren MichelleDirectorJun 27 '25Buy6.337,89849,99421,448Jul 01 05:06 PM
MCCABE JOAN YDirectorJun 27 '25Buy6.3215,82299,99546,180Jun 30 04:03 PM
Mehta NishilPresident and PEOJun 24 '25Buy6.0216,650100,23332,754Jun 25 04:17 PM
MCCABE JOAN YDirectorDec 18 '24Buy8.0218,079144,99430,358Dec 20 04:02 PM
Handa SanjeevDirectorDec 19 '24Buy7.984,38835,01510,388Dec 20 04:01 PM
SION - Sionna Therapeutics Inc - Stock Price Chart
TickerSION [NASD, RUT]
CompanySionna Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap838.36MEPS (ttm)-
P/E-EPS this Y83.43%
Forward P/E-EPS next Y-8.40%
PEG-EPS past 5Y-
P/S-EPS next 5Y40.90%
P/B2.38EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own46.69%Inst Own54.08%
Insider Trans20.68%Inst Trans33.40%
Short Float15.44%EarningsMay 12/b
Analyst Recom1.00Target Price38.50
Avg Volume177.81K52W Range7.26 - 25.19
Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in researching, developing and commercializing novel medicines for cystic fibrosis. It is focused on advancing a robust pipeline of small molecules and complementary CFTR modulators designed to deliver transformative clinical outcomes and improve the quality of life for individuals living with cystic fibrosis. The company was founded by Greg Hurlbut and Mark Munson in August 2019 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TPG GP A, LLC10% OwnerJun 27 '25Buy15.8460,000950,4006,744,962Jul 01 05:03 PM
TPG GP A, LLC10% OwnerFeb 10 '25Buy18.001,125,00020,250,0006,684,962Feb 12 05:21 PM
RA CAPITAL MANAGEMENT, L.P.DirectorFeb 10 '25Buy18.001,125,00020,250,0006,923,365Feb 10 05:04 PM
ORBIMED ADVISORS LLCDirectorFeb 10 '25Buy18.00550,0009,900,0003,704,959Feb 10 04:28 PM
Thompson Peter A.DirectorFeb 10 '25Buy18.00550,0009,900,0003,704,959Feb 10 04:05 PM
ANNX - Annexon Inc - Stock Price Chart
TickerANNX [NASD, RUT]
CompanyAnnexon Inc
CountryUSA
IndustryBiotechnology
Market Cap282.91MEPS (ttm)-1.17
P/E-EPS this Y-45.07%
Forward P/E-EPS next Y1.20%
PEG-EPS past 5Y-0.09%
P/S-EPS next 5Y2.82%
P/B1.16EPS Q/Q-78.85%
Dividend-Sales Q/Q-
Insider Own12.93%Inst Own87.98%
Insider Trans-0.27%Inst Trans-5.70%
Short Float10.52%EarningsMay 12/b
Analyst Recom1.00Target Price11.60
Avg Volume1.63M52W Range1.28 - 7.85
Jun-18-25 04:05PM Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy (GA) (GlobeNewswire)
May-29-25 04:05PM Annexon Biosciences to Present at the Jefferies Global Healthcare Conference (GlobeNewswire) +7.39% -6.42%
May-19-25 04:05PM Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting (GlobeNewswire)
04:05PM Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barre Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting (GlobeNewswire)
May-16-25 04:05PM Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +11.05%
May-12-25 08:00AM Annexon Reports First Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones (GlobeNewswire) +10.62%
May-09-25 05:00PM Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting (GlobeNewswire) -5.88%
05:00PM Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barre Syndrome (GBS) at the 2025 PNS Meeting (GlobeNewswire)
May-07-25 08:00AM Annexon to Present on the Neuroprotective Effects of ANX007 at the 2025 ARVO Annual Meeting and the Retina World Congress (GlobeNewswire)
Apr-16-25 04:05PM Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -7.14%
Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington's and alzheimer's disease, multiple sclerosis, glaucoma, parkinson's disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in Brisbane, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Yednock TedOfficerJul 14 '25Proposed Sale2.581,1162,881Jul 14 03:51 PM
Overdorf MichaelOfficerJul 14 '25Proposed Sale2.618532,226Jul 14 03:26 PM
Lew JenniferOfficerJul 14 '25Proposed Sale2.581,1172,881Jul 14 03:17 PM
Carson William H.DirectorJun 30 '25Buy2.464,11510,12329,715Jul 01 04:55 PM
Dananberg JamieCHIEF MEDICAL OFFICERFeb 18 '25Sale2.965,52116,34233,479Feb 20 04:54 PM
KFS - Kingsway Financial Services Inc - Stock Price Chart
TickerKFS [NYSE, RUT]
CompanyKingsway Financial Services Inc
CountryUSA
IndustryAuto & Truck Dealerships
Market Cap417.51MEPS (ttm)-0.37
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-5.78%
P/S3.64EPS next 5Y-
P/B71.85EPS Q/Q-65.23%
Dividend-Sales Q/Q7.71%
Insider Own29.70%Inst Own45.97%
Insider Trans-11.89%Inst Trans8.63%
Short Float3.16%Earnings-
Analyst Recom-Target Price-
Avg Volume72.10K52W Range7.06 - 16.80
Kingsway Financial Services, Inc. operates as a holding company. The firm engages in the provision of financial services. It operates through the following segments: Extended Warranty and Kingsway Search Xcelerator. The Extended Warranty segment includes excellent businesses in the Automotive and HVAC markets. It continues to expand its portfolio of high-quality operating companies through organic growth and disciplined M&A. The Kingsway Search Xcelerator segment is involved in review of billing rates and product prices are performed regularly and rates can be adjusted to reflect prevailing marketing expectations. The company was founded on September 19, 1989 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STILWELL JOSEPHDirectorJun 27 '25Sale14.03128,2431,799,596487,713Jul 01 05:52 PM
STILWELL JOSEPHDirectorJun 30 '25Sale13.9032,978458,556481,817Jul 01 05:52 PM
Fitzgerald John Taylor MaloneyPresident and CEOJul 01 '25Buy14.021792,5101,529,876Jul 01 04:52 PM
Hansen Kent ACFO & EVPJul 01 '25Buy14.021111,556135,248Jul 01 04:51 PM
Hansen Kent ACFO & EVPJun 13 '25Buy13.771141,570135,137Jun 16 04:00 PM
SWZ - Total Return Securities Fund - Stock Price Chart
TickerSWZ [NYSE]
CompanyTotal Return Securities Fund
CountryUSA
IndustryClosed-End Fund - Foreign
Market Cap81.00MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend4.59%Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float0.15%Earnings-
Analyst Recom-Target Price-
Avg Volume70.60K52W Range5.09 - 6.71
The Swiss Helvetia Fund Inc. is a closed-ended equity mutual fund launched and managed by Schroder Investment Management North America Inc. The fund invests in public equity markets of Switzerland. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in value stocks of companies across all market capitalizations. It employs fundamental analysis with a bottom-up stock picking approach, focusing on factors such as capital appreciation, income, economic and industry trends, quality of management, financial condition, business plan, industry and sector market position, dividend payout ratio, and corporate governance to create its portfolio. The fund benchmarks the performance of its portfolio against the S&P 500 Index and MSCI EAFE Index. It was previously known as The Helvetia Fund, Inc. The Swiss Helvetia Fund Inc. was formed in October 24, 1986 and is domiciled in the United States.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SELL MORITZ ADirectorJun 30 '25Buy6.341,81511,5073,400Jul 01 04:39 PM
HELLERMAN GERALDDirectorApr 02 '25Sale9.24413795,283Apr 03 04:05 PM
GOLDSTEIN PHILLIPDirectorJan 17 '25Sale8.454,53538,32112,248Jan 21 04:14 PM
SPG - Simon Property Group, Inc - Stock Price Chart
TickerSPG [NYSE, S&P 500]
CompanySimon Property Group, Inc
CountryUSA
IndustryREIT - Retail
Market Cap60.41BEPS (ttm)6.69
P/E23.93EPS this Y-12.01%
Forward P/E23.24EPS next Y7.88%
PEG-EPS past 5Y2.13%
P/S10.08EPS next 5Y-1.07%
P/B20.39EPS Q/Q-38.19%
Dividend5.30%Sales Q/Q2.11%
Insider Own0.93%Inst Own92.70%
Insider Trans0.14%Inst Trans2.68%
Short Float1.43%EarningsAug 04/a
Analyst Recom2.10Target Price182.47
Avg Volume1.62M52W Range136.34 - 190.13
Simon Property Group, Inc. is a self-administered and self-managed real estate investment trust, which engages in the ownership, development, and management of shopping, dining, entertainment, and mixed-used destinations, which consist primarily of malls, Premium Outlets, and the Mills. The company was founded by Fred Simon, Herbert Simon and Melvin Simon in 1993 and is headquartered in Indianapolis, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STEWART MARTA RDirectorJun 30 '25Buy159.2920833,13216,080Jul 01 04:30 PM
Smith Daniel C.DirectorJun 30 '25Buy159.2937860,21231,998Jul 01 04:28 PM
SELIG STEFAN MDirectorJun 30 '25Buy159.2921934,88531,881Jul 01 04:26 PM
Roe Peggy FangDirectorJun 30 '25Buy159.298613,6996,650Jul 01 04:23 PM
RODKIN GARY MDirectorJun 30 '25Buy159.2924639,18519,010Jul 01 04:21 PM
CDXS - Codexis Inc - Stock Price Chart
TickerCDXS [NASD, RUT]
CompanyCodexis Inc
CountryUSA
IndustryBiotechnology
Market Cap243.56MEPS (ttm)-0.99
P/E-EPS this Y22.15%
Forward P/E-EPS next Y17.01%
PEG-EPS past 5Y-33.31%
P/S4.89EPS next 5Y41.30%
P/B4.91EPS Q/Q-52.40%
Dividend-Sales Q/Q-55.82%
Insider Own3.23%Inst Own82.81%
Insider Trans140.25%Inst Trans7.64%
Short Float8.85%EarningsMay 14/a
Analyst Recom1.57Target Price7.08
Avg Volume828.52K52W Range1.90 - 6.08
Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Opaleye Management Inc.10% OwnerJun 27 '25Buy2.39100,000239,00012,350,000Jul 01 04:05 PM
Opaleye Management Inc.10% OwnerJun 12 '25Buy2.25100,000225,00012,100,000Jun 16 04:59 PM
Opaleye Management Inc.10% OwnerJun 13 '25Buy2.2399,102220,99712,199,102Jun 16 04:59 PM
Opaleye Management Inc.10% OwnerJun 16 '25Buy2.2450,898114,01212,250,000Jun 16 04:59 PM
Opaleye Management Inc.10% OwnerMay 23 '25Buy2.362,320,0005,475,20011,995,000May 28 04:05 PM
12345678910